Home » Authors » Nuala Moran

Articles by Nuala Moran

Scotia Moves Into Administration Following Rejection Of Foscan

Jan. 31, 2001

Eurogene Acquires Quattrogene, Phase II Product In Stock Deal

Jan. 31, 2001

London Exchange Might Ease Listing Rules For Young Firms

Jan. 24, 2001

Strong Placebo Effect In Phase II Causes Failed Phytopharm Trial

Jan. 24, 2001

IsoTis Completes Implants Of Autologous Living Bone Tissue

Jan. 24, 2001

Strong Placebo Effect In Phase II Causes Failed Phytopharm Trial

Jan. 24, 2001

IsoTis Completes Implants Of Autologous Living Bone Tissue

Jan. 24, 2001

London Exchange Might Ease Listing Rules For Young Firms

Jan. 24, 2001

Avidex Completes £10M Funding For Programs In T-Cell Receptors

Jan. 17, 2001

Cambridge Drug Eyes Licensing Deals Following £7.5M Financing

Jan. 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.